VVP
RBOT

Venture Visionary Partners’s Vicarious Surgical RBOT Stock Holding History

Venture Visionary Partners’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7
Closed -$588 – 1285
2022
Q2 		$588 Buy
+7
New +$856 ﹤0.01% 1636

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Venture Visionary Partners's RBOT Position: Q3 2022 in Review

Venture Visionary Partners sold out of Vicarious Surgical (RBOT) in Q3 2022, closing a stake of 7 shares — an estimated $588 sold.

Venture Visionary Partners first reported a position in RBOT in Q2 2022 and held it in 1 quarter. The position peaked at $588 in Q2 2022. 76 funds tracked by Wall St. Rank hold RBOT as of Q3 2022.

  • Venture Visionary Partners reported no remaining Vicarious Surgical position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 7 Vicarious Surgical shares in Q3 2022, an estimated $588.
  • Venture Visionary Partners first reported a position in Vicarious Surgical in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Vicarious Surgical position peaked at $588 in Q2 2022.
  • 76 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.